When was SciLogica founded?

SciLogica was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Where is SciLogica located?

SciLogica is headquartered in Denver, United States. It is registered at 9400 GARSINGTON ROAD,OXFORD BUSINESS PARK,OXFORD,UNITED KINGDOM,OX4 2HN.

Is SciLogica a funded company?

SciLogica is a funded company, having raised a total of $8.16M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on May 22, 2020.

When was the latest funding round of SciLogica?

SciLogica's latest funding was a $***** Conventional Debt round on Aug 01, 2022, with participation from 0 investor. Its primary sector is Hematology. In United States, the Hematology sector has seen $392M in funding in 2026 to date.

Where does SciLogica rank among its competitors?

SciLogica ranks 7th amongst 13 active competitors, of which 6 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Engineering for All, which secured $6.5M in Apr, 2024.

Who are the top competitors of SciLogica?

SciLogica's top competitors include Membio, Engineering for All and Beijing Zhizhen Biotechnology. Among them, Engineering for All secured the most recent funding round in April, 2024.

SciLogica - 2026 Company Profile, Funding & Competitors

SciLogica is a series A company based in Denver (United States), founded in 2019. It operates as a Developer of a continuous blood parameter monitoring platform for critical care healthcare. SciLogica has raised $8.16M in funding. The company has 13 active competitors, including 6 that are funded. Its top competitors include companies like Membio, Engineering for All and Beijing Zhizhen Biotechnology.

Company Details

Developer of a continuous blood parameter monitoring platform for critical care healthcare. The company offers Elucido a non-invasive device that uses electrochemical sensors for the continuous monitoring of blood analytes.

Website: scilogica.com
Registered Address: 9400 GARSINGTON ROAD,OXFORD BUSINESS PARK,OXFORD,UNITED KINGDOM,OX4 2HN

Key Metrics

Founded Year

2019

Location

Denver, United States

Stage

Series A

Total Funding

$8.16M in 2 rounds

Latest Funding Round

Conventional Debt, Aug 01, 2022, $*****

Ranked

7^th among 13 active competitors

Similar Companies

Membio & 17 more

View SciLogica's full profile

SciLogica is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SCILOGICA LTD CIN: 11864462 , United Kingdom, Active	Mar 05, 2019	-	5 (As on Dec 31, 2023)
SciLogica Corp CIN: 834455276 , United States, Active		$1 - $1M (As on May 19, 2021)	-	-

SciLogica has raised a total funding of $8.16M over 2 rounds. Its first funding round was on May 22, 2020.

Here is the list of recent funding rounds of SciLogica:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 01, 2022	7544628	Conventional Debt	4485033	6801329	1214003	8207424
May 22, 2020	4731348	Series A	3298078	1491312	8416787	3445725

Access funding benchmarks and valuations. Sign up today!

View details of SciLogica's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SciLogica include Membio, Engineering for All and Beijing Zhizhen Biotechnology. Here is the list of Top 10 competitors of SciLogica, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Membio 2018, Kitchener (Canada), Seed	Developer of single-use bioreactors for cell and gene therapies	$280K	IndieBio, Accelerator Centre & 6 others	40/100
2nd	Engineering for All 2016, Yokneam Illit (Israel), Series A	Provider of point of care diagnostic device	$7.4M	eHealth Ventures, Innovation Israel & 5 others	38/100
3rd	Beijing Zhizhen Biotechnology 2017, Beijing (China), Series B	Provider of hematology testing instruments, reagents, and services	$17.8M	Fortune Capital, Shanghai Shengyu Equity Investment Fund Management ... & 8 others	38/100
4th	CIMON Medical 2018, Trondheim (Norway), Seed	Developer of a patented device for monitoring blood flow for early diagnosis	$6.81M	ProVenture, Farvatn Venture & 5 others	35/100
5th	Kalium Health 2018, Cambridge (United Kingdom), Seed	Developer of device for monitoring blood potassium	$1.22M	Cambridge Enterprise, Martlet Capital & 20 others	33/100
6th	Sphere Medical 2002, Cambridge (United Kingdom), Deadpooled	Monitoring devices for use in the ICU and OR	$11.9M	Herald Investment Management, Artemis Investment Management ... & 10 others	33/100
7th	SciLogica 2019, Denver (United States), Series A	Developer of a continuous blood parameter monitoring platform for critical care healthcare	$8.16M	-	32/100
8th	LiteBC 2020, Israel, Funding Raised	Developer of smart devices for monitoring blood cells within the body	-	Entree Capital, Technion DRIVE Accelerator	31/100
9th	ToxCO 2019, Maidstone (United Kingdom), Unfunded	Developer of a breath monitoring device to detect carbon monoxide poisoning	-	-	29/100
10th	HemaSense 2024, Flagstaff (United States), Unfunded	Developer of solutions for early detection and management of blood-related conditions	-	-	28/100